Page last updated: 2024-10-24

busulfan and Common Variable Hypogammaglobulinemia

busulfan has been researched along with Common Variable Hypogammaglobulinemia in 1 studies

Research Excerpts

ExcerptRelevanceReference
"In high-risk malignancy, low acute toxicity was followed by low TRM but it did not translate into increased survival."2.78Long-term follow-up of children conditioned with Treosulfan: German and Austrian experience. ( Bader, P; Beier, R; Ehlert, K; Eyrich, M; Greil, J; Gruhn, B; Holter, W; Hönig, M; Meisel, R; Müller, I; Nürnberger, W; Sauer, M; Schlegel, PG; Schulz, A; Stachel, KD; Suttorp, M; Sykora, KW; Urban, C; Wössmann, W; Zimmermann, M, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beier, R1
Schulz, A1
Hönig, M1
Eyrich, M1
Schlegel, PG1
Holter, W1
Stachel, KD1
Ehlert, K1
Greil, J1
Nürnberger, W1
Wössmann, W1
Bader, P1
Urban, C1
Müller, I1
Suttorp, M1
Sauer, M1
Gruhn, B1
Meisel, R1
Zimmermann, M1
Sykora, KW1

Trials

1 trial available for busulfan and Common Variable Hypogammaglobulinemia

ArticleYear
Long-term follow-up of children conditioned with Treosulfan: German and Austrian experience.
    Bone marrow transplantation, 2013, Volume: 48, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Austria; Bone Marrow Transplantation; Busulfan

2013